NYSE:ABBV

Abbvie Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy ABBV

*Your capital is at risk

$217.07

+1.64 (+0.761%)

At Close: Jun 03, 2026

AbbVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -31.34. In total, the insiders bought 778.69K and sold 29.8M ABBV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-31.34
● Buy	778.69K shares
● Sell	29.8M shares
79% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -31.34. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Purdue David Ryan SVP, Controller	Officer	2 505 Value: $572.9K
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Purdue David Ryan SVP, Controller	Officer	1 292 Value: $295.5K
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	7 074 Value: $1.62M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	17 041 Value: $3.90M
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Crum Demetris D EVP, Chief Hr Officer	Officer	13 406 Value: $3.08M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Crum Demetris D EVP, Chief Hr Officer	Officer	1 216 Value: $278.1K
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	5 172 Value: $1.18M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	4 632 Value: $1.06M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	7 606 Value: $1.74M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	8 910 Value: $2.04M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Purdue David Ryan SVP, Controller	Officer	1 384 Value: $316.5K
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Thakkar Roopal EVP, R&d And Cso	Officer	6 015 Value: $1.38M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Thakkar Roopal EVP, R&d And Cso	Officer	3 346 Value: $765.3K
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Thakkar Roopal EVP, R&d And Cso	Officer	6 638 Value: $1.52M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Thakkar Roopal EVP, R&d And Cso	Officer	2 138 Value: $489.0K
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Thakkar Roopal EVP, R&d And Cso	Officer	21 937 Value: $5.05M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Purdue David Ryan SVP, Controller	Officer	890 Value: $203.6K
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Purdue David Ryan SVP, Controller	Officer	4 875 Value: $1.12M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	9 432 Value: $2.16M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	26 063 Value: $5.96M
Feb 18, 2026 Buy	Option (Right to Buy) A-Award	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	26 812 Value: $6.17M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Siatis Perry C EVP, GC And Secretary	Officer	5 628 Value: $1.29M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Siatis Perry C EVP, GC And Secretary	Officer	16 290 Value: $3.73M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	6 638 Value: $1.52M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	25 062 Value: $5.73M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBVIE INC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...

Read Full Profile Here